RASAGILINE MESYLATE

N/A

Manufactured by Teva Neuroscience, Inc.

23,100 FDA adverse event reports analyzed

Last updated: 2026-04-14

About RASAGILINE MESYLATE

RASAGILINE MESYLATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Teva Neuroscience, Inc.. The most commonly reported adverse reactions for RASAGILINE MESYLATE include FALL, HALLUCINATION, DYSKINESIA, DRUG INEFFECTIVE, TREMOR. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for RASAGILINE MESYLATE.

Top Adverse Reactions

FALL1,027 reports
HALLUCINATION909 reports
DYSKINESIA735 reports
DRUG INEFFECTIVE723 reports
TREMOR631 reports
DIZZINESS622 reports
DEATH594 reports
CONFUSIONAL STATE527 reports
PARKINSON^S DISEASE516 reports
SOMNOLENCE485 reports
GAIT DISTURBANCE481 reports
NAUSEA472 reports
FATIGUE452 reports
CONSTIPATION388 reports
INSOMNIA365 reports
DRUG INTERACTION354 reports
ANXIETY348 reports
CONDITION AGGRAVATED333 reports
ASTHENIA320 reports
MALAISE318 reports
BALANCE DISORDER312 reports
WEIGHT DECREASED297 reports
FEELING ABNORMAL287 reports
HYPOTENSION285 reports
HALLUCINATION, VISUAL279 reports
DYSPNOEA262 reports
COUGH247 reports
URINARY TRACT INFECTION242 reports
ON AND OFF PHENOMENON228 reports
OFF LABEL USE220 reports
HEADACHE217 reports
PAIN217 reports
DEPRESSION209 reports
MUSCULOSKELETAL STIFFNESS209 reports
PRODUCT DOSE OMISSION ISSUE206 reports
VOMITING206 reports
DYSPHAGIA202 reports
PNEUMONIA200 reports
SPEECH DISORDER199 reports
FREEZING PHENOMENON196 reports
MOBILITY DECREASED196 reports
ORTHOSTATIC HYPOTENSION194 reports
DECREASED APPETITE192 reports
AGITATION189 reports
DELUSION188 reports
DIARRHOEA187 reports
HYPERHIDROSIS183 reports
SEROTONIN SYNDROME182 reports
HYPERTENSION177 reports
DEVICE ISSUE174 reports
SYNCOPE172 reports
LOSS OF CONSCIOUSNESS160 reports
PERIPHERAL SWELLING159 reports
MUSCLE SPASMS155 reports
GENERAL PHYSICAL HEALTH DETERIORATION154 reports
MEMORY IMPAIRMENT150 reports
BACK PAIN148 reports
BLOOD PRESSURE INCREASED148 reports
SLEEP DISORDER144 reports
MUSCLE RIGIDITY143 reports
PYREXIA142 reports
THERAPEUTIC RESPONSE SHORTENED140 reports
ABNORMAL BEHAVIOUR139 reports
ARTHRALGIA137 reports
PAIN IN EXTREMITY135 reports
AGGRESSION133 reports
COGNITIVE DISORDER131 reports
DEVICE DISLOCATION131 reports
BLOOD PRESSURE DECREASED129 reports
BRADYKINESIA129 reports
DEHYDRATION127 reports
DYSTONIA124 reports
MUSCULAR WEAKNESS124 reports
DEMENTIA123 reports
DRY MOUTH123 reports
HYPERSEXUALITY118 reports
DELIRIUM117 reports
RASH113 reports
OEDEMA PERIPHERAL111 reports
ABDOMINAL PAIN109 reports
IMPULSE CONTROL DISORDER109 reports
HIP FRACTURE103 reports
RESTLESSNESS102 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE101 reports
ABNORMAL DREAMS99 reports
DISORIENTATION98 reports
ADVERSE DRUG REACTION95 reports
DEVICE OCCLUSION94 reports
DISTURBANCE IN ATTENTION94 reports
STOMA SITE DISCHARGE91 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS91 reports
MOVEMENT DISORDER90 reports
PSYCHOTIC DISORDER90 reports
UNEVALUABLE EVENT89 reports
CEREBROVASCULAR ACCIDENT88 reports
DYSARTHRIA86 reports
PNEUMONIA ASPIRATION84 reports
PRURITUS83 reports
NIGHTMARE82 reports
HYPOAESTHESIA81 reports

Report Outcomes

Out of 10,680 classified reports for RASAGILINE MESYLATE:

Serious 65.9%Non-Serious 34.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male5,853 (59.6%)
Female3,942 (40.1%)
Unknown32 (0.3%)

Reports by Age

Age 75284 reports
Age 76284 reports
Age 71282 reports
Age 74278 reports
Age 69274 reports
Age 70274 reports
Age 77266 reports
Age 78259 reports
Age 68247 reports
Age 73247 reports
Age 72231 reports
Age 79217 reports
Age 67213 reports
Age 80209 reports
Age 66197 reports
Age 65189 reports
Age 81160 reports
Age 82150 reports
Age 63149 reports
Age 62148 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with RASAGILINE MESYLATE?

This profile reflects 23,100 FDA FAERS reports that mention RASAGILINE MESYLATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for RASAGILINE MESYLATE?

Frequently reported terms in FAERS include FALL, HALLUCINATION, DYSKINESIA, DRUG INEFFECTIVE, TREMOR, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures RASAGILINE MESYLATE?

Labeling and FAERS entries often list Teva Neuroscience, Inc. in connection with RASAGILINE MESYLATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.